Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.
- 1 February 1991
- journal article
- Vol. 23, 949-53
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506Annals of Surgery, 1990
- Prevention of spontaneous diabetes in BB rats with FK 506The Lancet, 1990
- IN VITRO EFFECTS OF FK-506 ON HUMAN AND RAT ISLETSTransplantation, 1990
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteinsNature, 1989
- Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilinNature, 1989
- A COMPARISON OF THE CLINICAL UTILITY OF THE RADIOIMMUNOASSAY, HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, AND TDx CYCLOSPORINE ASSAYS IN OUTPATIENT RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- IMPAIRED GLUCOSE TOLERANCE IN CYCLOSPORINE-PREDNISOLONE-TREATED RENAL GRAFT RECIPIENTSTransplantation, 1988
- The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomeraseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985